At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 112 enrolled
Drug / intervention
liposomal bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ultrasound-guided Pec Infiltration With Liposomal Bupivacaine for Breast Surgery: A Prospective Randomized Study
In Brief
A Phase 4 clinical trial evaluating liposomal bupivacaine and Bupivacaine for Acute Pain. Completed, enrolled 112 participants across 1 site.
Detailed Summary
The purpose of this study is to compare pain control after breast surgery using either liposomal bupivacaine or bupivacaine when infiltrated during an ultrasound guided pectoralis 1 and 2 block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care in these types of surgeries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedJul 2018
Primary CompletionJul 2024
TodayJul 2026
First PostedJul 26, 2018
Enrollment StartJul 1, 2018
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 7.9 years ago
Interventions
liposomal bupivacainedrug
Experimental
Bupivacainedrug
Active Comparator